Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.23.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid in capital
Retained earnings
Accumulated other comprehensive loss
Total equity attributable to the shareholders
Non-controlling interest
Shares issued, beginning of period (in shares) at Mar. 31, 2020   58,358,212,000          
Equity, beginning of period at Mar. 31, 2020 $ 149,369 $ 58 $ 131,811 $ 64,780 $ (45,008) $ 151,641 $ (2,272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation (in shares)   15,000,000          
Stock based compensation 1,147   1,147     1,147  
Share based payment (in shares)   10,000,000          
Share based payment 517   517     517  
Exercise of options (in shares)   60,000,000          
Exercise of options 118   118     118  
Capital contribution of Shareholder 1,667   1,667     1,667  
Other comprehensive reserve 2,092            
Other comprehensive reserve 1,788       1,788 1,788  
Foreign currency translation adjustments, net of tax effect 2,787       2,787 2,787  
Net income 150,281     149,650   149,650 631
Shares issued, end of period (in shares) at Mar. 31, 2021   58,443,212,000          
Equity, end of period at Mar. 31, 2021 307,674 $ 58 135,260 214,430 (40,433) 309,315 (1,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation (in shares)   1,039,000,000          
Stock based compensation 15,746 $ 1 15,745     15,746  
Exercise of options (in shares)   60,000,000          
Exercise of options 119   119     119  
Capital contribution of Shareholder 24,417   24,417     24,417  
Other comprehensive reserve 2,222            
Sale of Freedom UA shares 416   (796)     (796) 1,212
Other comprehensive reserve (2,070)       (2,070) (2,070)  
Foreign currency translation adjustments, net of tax effect (20,622)       (20,622) (20,622)  
Net income 220,928     227,494   227,494 (6,566)
Shares issued, end of period (in shares) at Mar. 31, 2022   59,542,212,000          
Equity, end of period at Mar. 31, 2022 546,608 $ 59 174,745 441,924 (63,125) 553,603 (6,995)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation (in shares)   57,216,000          
Stock based compensation 11,038   11,038     11,038  
Exercise of options (in shares)   59,763,000          
Capital contribution of Shareholder 677   677     677  
Other comprehensive reserve (2,916)            
Issuance of shares of common stock 4,290   4,290     4,290  
Acquisition of insurance companies (26,588)   (26,588)     (26,588)  
Other comprehensive reserve (1,485)       (1,485) (1,485)  
Reclassification of loss from cumulative translation adjustment of discontinued operations 25,415     0 25,415 25,415  
Foreign currency translation adjustments, net of tax effect 5,195       5,195 5,195  
Net income 205,586            
Net income 205,586     205,140   205,140 446
Shares issued, end of period (in shares) at Mar. 31, 2023   59,659,191,000          
Equity, end of period at Mar. 31, 2023 $ 770,736 $ 59 $ 164,162 $ 647,064 $ (34,000) $ 777,285 $ (6,549)